Vallejo-Cordoba et al., 2020 - Google Patents
Postbiotics and paraprobiotics: A review of current evidence and emerging trendsVallejo-Cordoba et al., 2020
- Document ID
- 16372011723143344471
- Author
- Vallejo-Cordoba B
- Castro-López C
- García H
- González-Córdova A
- Hernández-Mendoza A
- Publication year
- Publication venue
- Advances in food and nutrition research
External Links
Snippet
In recent years, new probiotic-related concepts such as postbiotics and paraprobiotics have been coined to indicate that non-viable microorganisms or bacterial-free extracts may provide benefits to the host by offering additional bioactivities to probiotics, including but not …
- 239000006041 probiotic 0 abstract description 97
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vallejo-Cordoba et al. | Postbiotics and paraprobiotics: A review of current evidence and emerging trends | |
| Cuevas-González et al. | Postbiotics and paraprobiotics: From concepts to applications | |
| Sabahi et al. | Postbiotics as the new frontier in food and pharmaceutical research | |
| JP6608047B2 (en) | Novel lactic acid bacteria having various functions and uses thereof | |
| Shi et al. | Beneficial properties of probiotics | |
| Bomba et al. | Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids | |
| Bomba et al. | The possibilities of potentiating the efficacy of probiotics | |
| Toh et al. | Probiotic therapy as a novel approach for allergic disease | |
| Taverniti et al. | Health-promoting properties of Lactobacillus helveticus | |
| Zhao et al. | Lactobacillus fermentum and its potential immunomodulatory properties | |
| Castillo et al. | Probiotics: an alternative strategy for combating salmonellosis: immune mechanisms involved | |
| Faghfoori et al. | Cellular and molecular mechanisms of probiotics effects on colorectal cancer | |
| RU2603059C2 (en) | Isolated strains of lactobacillus plantarum dsm mcc1 23881 and lactobacillus gasseri mcc2 dsm 23882 microorganisms, and use thereof | |
| RU2759600C2 (en) | Use of carotenoid of microbial origin that affects composition of intestinal microorganisms | |
| AU2010288546A1 (en) | Bifidobacterium longum and functional GI disorders | |
| Jiang et al. | Effects of supplementation with Lactobacillus plantarum 299v on the performance, blood metabolites, rumen fermentation and bacterial communities of preweaning calves | |
| JP4712289B2 (en) | Immune promoting composition | |
| Abbasi et al. | Postbiotics: science, technology and applications | |
| Pimentel et al. | Postbiotics: An overview of concepts, inactivation technologies, health effects, and driver trends | |
| Illikoud et al. | Dairy starters and fermented dairy products modulate gut mucosal immunity | |
| Homayouni-Rad et al. | Evaluating the role of postbiotics as a new generation of probiotics in health and diseases | |
| Chen et al. | Kefir microbiota and metabolites stimulate intestinal mucosal immunity and its early development | |
| Saeed et al. | Use of postbiotic as growth promoter in poultry industry: A review of current knowledge and future prospects | |
| Kurpad | Potential of probiotics in hypercholesterolemia: a review of in vitro and in vivo findings | |
| Yoda et al. | Oral administration of Lactobacillus gasseri TMC0356 stimulates peritoneal macrophages and attenuates general symptoms caused by enteropathogenic Escherichia coli infection |